Skip to main content
SpringerLink
Log in

Radiation Therapy for Clinically Localized Prostate Cancer

  • Chapter
Urological Oncology

  • 763 Accesses

Abstract

Radiation therapy (RT) is one of the two main local treatments for clinically localized prostate cancer; radical prostatectomy (RP) is the other. The treatment options that are available for a particular patient are extensive and can include expectant management, RP, external beam radiation therapy (EBRT), interstitial brachytherapy (IB), androgen deprivation therapy (ADT), or any combination of these.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D’Amico AV, Schultz D, Loffredo M, et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA 2000;284(10):1280–1283.

    Article  PubMed  Google Scholar 

  2. D’Amico AV, Moul J, Carroll PR, et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003;21(11):2163–2172.

    Article  PubMed  Google Scholar 

  3. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999;281(17): 1598–1604.

    Article  CAS  PubMed  Google Scholar 

  4. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294(10):1233–1239.

    Article  CAS  PubMed  Google Scholar 

  5. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097–1105.

    Article  PubMed  Google Scholar 

  6. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53(5):1111–1116.

    Article  PubMed  Google Scholar 

  7. Ragde H, Korb LJ, Elgamal AA, Grado GL, Nadir BS. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 2000;89(1):135–141.

    Article  CAS  PubMed  Google Scholar 

  8. Blasko JC, Grimm PD, Sylsvester JE, Cavanagh W. The role of external beam radio-therapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 2000;57(3):273–278.

    Article  CAS  PubMed  Google Scholar 

  9. Lederman GS, Cavanagh W, Albert PS, et al. Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy. Int J Radiat Oncol Biol Phys 2001;49(5): 1297–1303.

    CAS  PubMed  Google Scholar 

  10. Critz FA, Williams WH, Levinson AK, et al. Simultaneous irradiation for prostate cancer: intermediate results with modern techniques. J Urol 2000; 164 (3 pt 1): 738–741.

    Article  CAS  PubMed  Google Scholar 

  11. Dattoli M, Wallner K, True L, Cash J, Sorace R. Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase. Cancer 2003;97(4): 979–983.

    Article  PubMed  Google Scholar 

  12. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281(17):1591–1597.

    Article  CAS  PubMed  Google Scholar 

  13. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005; 366(9485):572–578.

    Article  PubMed  Google Scholar 

  14. Stephenson AJ, Shariat SF, Zelefsky MJ, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004;291(11):1325–1332.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA

    Michael A. Papagikos MD & W. Robert Lee MD, MS

Authors
  1. Michael A. Papagikos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Robert Lee MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Bartholomew’s and Homerton Hospitals Queen Mary Barts and the London School of Medicine and Dentistry, University of London, London, UK

    Vinod H. Nargund PhD, FRCS (Urol), FEBU (Chair, Uro-Oncology MDT and Consultant Urological Surgeon) (Chair, Uro-Oncology MDT and Consultant Urological Surgeon)

  2. Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA

    Derek Raghavan MD, PhD, FACP, FRACP (Chairman and Director) (Chairman and Director)

  3. Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA

    Howard M. Sandler MD (Professor and Senior Associate Chair) (Professor and Senior Associate Chair)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Papagikos, M.A., Lee, W.R. (2008). Radiation Therapy for Clinically Localized Prostate Cancer. In: Nargund, V.H., Raghavan, D., Sandler, H.M. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-1-84628-738-1_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-738-1_29

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-387-1

  • Online ISBN: 978-1-84628-738-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation